Sinil Pharmaceutical Co., Ltd. (Shinil Pharm) aksje
012790.KQ
StengtShinil Pharm
Market Cap
$59,762,929,664
Om Sinil Pharmaceutical Co., Ltd. (Shinil Pharm) aksje
Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.
Selskapsinformasjon
Chungju-si, South Korea
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.